For Research Use Only. Not for human or veterinary use.
Overview CJC-1295 (with DAC) is a synthetic 30-amino acid analogue of growth hormone-releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) via a lysine linker. The DAC modification facilitates covalent binding to serum albumin, a property of significant interest in pharmacokinetic and receptor binding research. It is widely investigated in neuroendocrine and endocrinological research settings for its interactions with GHRH receptors and downstream signalling pathways. This product is supplied as a lyophilised vial, verified at ≥99% purity by HPLC prior to dispatch.
Specifications
|
CJC-1295 (With DAC) |
| CAS |
863288-34-0 |
| Molecular Formula |
C₁₆₅H₂₆₉N₄₇O₄₆ |
| MW |
3,647.1 g/mol |
| Purity |
≥99% HPLC |
| Form |
Lyophilised powder |
| Vial |
2mg / 5mg |
Storage & Handling Store at −20°C away from direct light and moisture. Reconstitute under appropriate laboratory conditions. Certificate of Analysis available on request.
Intended Use Supplied strictly for in vitro and in vivo laboratory research by qualified researchers. Not for human or veterinary use, diagnostic procedures, food, supplements, or cosmetic applications.
Not evaluated by the TGA or any regulatory authority for safety or efficacy in humans or animals.
